Non-Stress Test (NST): Complete Pregnancy Monitoring Guide

A Non-Stress Test (NST) is a non-invasive prenatal monitoring procedure that evaluates fetal well-being by measuring fetal heart rate patterns in response to fetal movement. The term "non-stress" refers to the absence of stress induction (unlike the contraction stress test), making it a safe, low-risk assessment tool. During an NST, two belts are placed on the mother's abdomen—one to measure fetal heart rate and another to detect uterine contractions. The test typically takes 20-40 minutes and is considered reassuring (reactive) when the fetal heart rate accelerates appropriately with movement. NST is commonly recommended for pregnancies complicated by diabetes, hypertension, decreased fetal movement, post-dates, or intrauterine growth restriction. Understanding the indications, procedure, result interpretation, and clinical significance helps expectant mothers participate actively in their prenatal care.

A Non-Stress Test (NST) is a fundamental tool in antepartum fetal surveillance that assesses fetal well-being by monitoring fetal heart rate patterns and their relationship to fetal movement. Unlike other fetal assessments that may involve stress induction, the NST simply observes the fetus in its natural state, hence the term "non-stress."

Core principle: A healthy, well-oxygenated fetus with an intact neurological system will demonstrate heart rate accelerations in response to movement. The presence of these accelerations indicates fetal well-being, while their absence may indicate compromise requiring further evaluation.

Key components:

• Fetal heart rate monitoring: Continuous external Doppler ultrasound
• Movement detection: Maternal perception or tocodynamometry
• Contraction monitoring: Identifies uterine activity
• Duration: Typically 20-40 minutes
• Safety: No risk to mother or baby

Historical context: NST became widely adopted in the 1970s as advances in electronic fetal monitoring made continuous heart rate assessment possible. It has since become the most commonly used test for antepartum fetal surveillance.

NST is primarily recommended in the third trimester (typically after 28 weeks) for pregnancies at increased risk of adverse outcomes. The test identifies fetuses that may be experiencing compromise and require intervention.

Common Indications for NST

Maternal Conditions

Fetal Conditions

Pregnancy Complications

Testing Frequency

Understanding the physiological basis of NST helps explain what the test measures and why it's effective.

Normal Fetal Heart Rate Patterns

Baseline fetal heart rate:

• Normal range: 110-160 beats per minute (bpm)
• Maintained by autonomic nervous system
• Varies with gestational age
• Influenced by fetal sleep-wake cycles

Heart rate variability:

• Normal fluctuation around baseline
• Indicates intact autonomic nervous system
• Absence concerning for fetal compromise
• Measured as amplitude of fluctuations

Accelerations:

• Abrupt increase in heart rate
• Minimum 15 bpm above baseline
• Lasting at least 15 seconds
• Associated with fetal movement
• Indicates fetal well-being

Neurological Basis of NST

Normal physiology:

1. Fetal movement occurs
2. Sensory receptors detect movement
3. Neural signals transmitted to brainstem
4. Cardiac accelerator center stimulated
5. Heart rate increases (acceleration)
6. Heart rate returns to baseline

Abnormal physiology:

1. Fetal movement occurs
2. Neural system compromised (hypoxia, acidosis)
3. Signal transmission impaired
4. No acceleration (non-reactive NST)
5. Indicates potential fetal compromise

Critical concept: The presence of accelerations indicates adequate fetal oxygenation and neurological function. Their absence doesn't confirm fetal compromise but warrants further evaluation.

Before the Test

Preparation:

• No special preparation required
• Eat beforehand: Baby may be more active after meal
• Bring partner or support person: For anxiety reduction
• Hydration: Drink water before appointment (optional)
• Clothing: Wear loose, comfortable clothing exposing abdomen

What to bring:

• Insurance card
• Photo ID
• Previous NST records (if applicable)
• List of current medications
• Questions for healthcare provider

During the Test

Setup (5-10 minutes):

1. Position: Semi-recumbent or left lateral position
2. Abdomen exposed
3. Two belts applied:
   • Upper belt: Fetal heart rate transducer (Doppler)
   • Lower belt: Tocodynamometer (contraction sensor)
4. Gel applied to improve conduction
5. Heart rate located and confirmed

Testing phase (20-40 minutes):

1. Continuous fetal heart rate monitoring
2. Contractions recorded (if any)
3. Mother presses button when feels movement
4. Heart rate response to movement documented
5. Baseline heart rate established
6. Accelerations identified and counted

Extended monitoring:

• If no accelerations in 20-40 minutes
• Fetal acoustic stimulation may be used
• Loud noise applied to abdomen to wake fetus
• Additional 20 minutes of monitoring
• Total duration up to 90-120 minutes maximum

After the Test

Immediate results:

• Reactive: Normal result, usually sent home
• Non-reactive: Abnormal result, further evaluation
• Unsatisfactory: Poor tracing quality, repeat needed

Documentation:

• Official report generated
• Results sent to ordering provider
• Follow-up instructions provided
• Next NST scheduled if indicated

NST results are classified as reactive (normal) or non-reactive (abnormal) based on specific criteria.

Reactive NST (Normal Result)

Definition (ACOG criteria):

• Two or more accelerations within 20 minutes
• Each acceleration ≥15 bpm above baseline
• Each lasting ≥15 seconds
• In fetuses ＜32 weeks: ≥10 bpm above baseline, ≥10 seconds

Clinical significance:

• Indicates fetal well-being
• Predicts fetal acidemia unlikely
• No immediate intervention required
• Continue routine monitoring

False reassurance rate: 0.5-1% (rarely, problems occur despite reactive NST)

Non-Reactive NST (Abnormal Result)

Definition:

• Fewer than two accelerations in 40 minutes
• No adequate accelerations despite extended monitoring
• May have other abnormal findings:
  • Decreased variability
  • Decelerations
  • Abnormal baseline rate

Clinical significance:

• Does NOT confirm fetal compromise
• Indicates need for further evaluation
• Risk assessment based on overall clinical picture

Additional Testing After Non-Reactive NST

NST Classification System

Several factors can influence NST results and interpretation, independent of fetal well-being.

Physiological Factors

Fetal sleep cycles:

• Fetuses have sleep-wake cycles
• Quiet sleep: 20-40 minutes
• No movement or accelerations during sleep
• May cause false non-reactive result
• Extended monitoring accounts for this

Gestational age:

• Before 28 weeks: Accelerations less reliable
• 28-32 weeks: Acceleration criteria modified (10 bpm)
• After 32 weeks: Standard criteria apply
• After 40 weeks: Increased baseline variability expected

Maternal medications:

Technical Factors

Maternal body habitus:

• Obesity: Poor signal transmission
• Anterior placenta: May reduce signal quality
• Scarring: From previous surgeries

Equipment issues:

• Transducer placement
• Belt tightness
• Interference from maternal movement
• Equipment malfunction

Environmental factors:

• Room temperature (maternal comfort)
• Maternal anxiety (affects fetal movement)
• Time of day (fetal activity patterns)

Typical NST Workflow

At each NST visit:

1. Check vital signs (blood pressure, weight)
2. Discuss fetal movement since last visit
3. Review any new symptoms
4. Perform NST (20-40 minutes)
5. Interpret results
6. Determine management plan:
   • Reactive: Schedule next NST
   • Non-reactive: Additional testing
   • Concerning: Consider delivery

Frequency of monitoring:

• Twice weekly: Most common high-risk frequency
• Progression: May increase as pregnancy advances
• Indication-specific: Varies by underlying condition
• Postdates: Typically 2-3 times per week

Outpatient vs. Inpatient NST

Outpatient NST:

• Location: Office or clinic
• Duration: 30-60 minutes total
• Indications: Stable high-risk conditions
• Advantages: Convenient, less costly
• Most common: Majority of NSTs performed outpatient

Inpatient NST:

• Location: Hospital antepartum unit
• Frequency: May be daily or continuous
• Indications: Unstable conditions, very high risk
• Advantages: Immediate intervention capability
• Common for: Severe preeclampsia, IUGR, etc.

NST in Multiple Gestation

Challenges:

• Monitoring each fetus separately
• Signal confusion between babies
• Longer testing duration
• Different gestational ages (rare in twins)

Approach:

• Separate heart rate monitors for each fetus
• May require Doppler ultrasound for each
• Extended monitoring time (45-60 minutes)
• Individual assessment of each baby

Success rate: 85-90% get adequate tracings for both twins

NST with Decreased Fetal Movement

Clinical approach:

1. Immediate NST: When mother reports decreased movement
2. Extended monitoring: If initial NST non-reactive
3. Biophysical profile: Often added for comprehensive assessment
4. Delivery consideration: If testing concerning

Important: Never ignore decreased fetal movement. Always report promptly.

NST in Postdates Pregnancy

Rationale:

• Placental function decreases after 40-41 weeks
• Stillbirth risk increases after 41 weeks
• NST identifies compromised fetuses

Protocol:

• Start: At 41 weeks (or 40+6 depending on provider)
• Frequency: 2-3 times per week
• Additional testing: Amniotic fluid assessment (AFI)
• Delivery: Scheduled if testing abnormal or by 42 weeks

Outcome: NST with AFI reduces postdates stillbirth risk by 50%+

Test Performance Characteristics

False Negative Results

Definition: Reactive NST but fetus compromised

Rate: 0.5-1%

Causes:

• Acute event after NST (cord accident, abruption)
• Progressive condition developing after test
• Test performed during brief well period

Clinical reality: No test perfect. Continued monitoring essential.

False Positive Results

Definition: Non-reactive NST but fetus healthy

Rate: 20-30%

Causes:

• Fetal sleep during test
• Maternal medications
• Technical factors
• Premature gestational age

Clinical approach: Additional testing (usually BPP) distinguishes true from false positives.

Does NST hurt?

No, NST is completely painless. The procedure involves:

• Belt placement: Mild pressure, not painful
• Monitoring: External sensors, no internal devices
• Duration: May be uncomfortable lying still for 20-40 minutes
• Acoustic stimulation: Loud noise if used (startling but not painful)

Potential discomforts:

• Back discomfort from lying still
• Pressure from belts
• Boredom/frustration if test extended
• Anxiety about results

Tips: Bring entertainment (book, music), use pillows for comfort, empty bladder beforehand.

What if the NST is non-reactive?

A non-reactive NST does NOT mean your baby is in danger. It means:

• Further evaluation needed: Usually a Biophysical Profile (BPP)
• Most are false positives: 70-80% of non-reactive NSTs have healthy babies
• Additional testing provides clarity: BPP more comprehensive
• Action plan developed: Based on all available information

Next steps after non-reactive NST:

1. BPP performed (ultrasound assessment)
2. Results reviewed
3. Management plan determined
4. Most go home with continued monitoring
5. Some require delivery (rare, usually obvious compromise)

How often will I need NST?

Frequency depends on your specific situation:

Your provider will individualize frequency based on your specific risk factors.

Can I eat before an NST?

Yes, eating before an NST is actually encouraged. There's no fasting requirement.

Benefits of eating before NST:

• Increases fetal movement: Baby more active after maternal meals
• May shorten test duration: More movement = quicker accelerations
• Maternal comfort: Prevents hunger/lightheadedness during test
• Blood sugar stability: Especially important for diabetics

Best choices:

• Light meal or snack 30-60 minutes before
• Avoid excessive sugar (can cause rebound sleepiness)
• Stay hydrated
• Avoid caffeine (unless part of normal routine)

What does a reactive NST mean for my baby?

A reactive NST is reassuring and indicates:

• Fetal well-being likely: Baby appears healthy
• Adequate oxygenation: Baby not hypoxic
• Intact neurological system: Baby responds normally to movement
• Low immediate risk: Serious problems unlikely at this moment

However, reactive NST does NOT guarantee:

• Perfect health (some problems not detectable)
• Future well-being (conditions can develop)
• Labor outcome (still need monitoring during delivery)
• No need for continued monitoring (usually continue per schedule)

Bottom line: Reactive NST is good news, but continued monitoring per your provider's plan is still important.

1. NST measures fetal heart rate accelerations in response to movement, assessing neurological function and oxygenation.

2. Reactive NST requires two accelerations (≥15 bpm for ≥15 seconds) within 20 minutes, indicating fetal well-being.

3. Non-reactive NST occurs in 15-20% of tests but only 20-30% of those indicate actual fetal compromise—most are false positives.

4. Biophysical Profile (BPP) is the standard follow-up test for non-reactive NST, providing comprehensive fetal assessment.

5. NST typically starts at 28-36 weeks for high-risk pregnancies and continues once or twice weekly until delivery.

6. Fetal sleep cycles can cause temporarily non-reactive results, necessitating extended monitoring up to 90-120 minutes.

7. Common indications include diabetes, hypertension, IUGR, decreased fetal movement, and postdates pregnancy.

8. Acoustic stimulation (loud noise) may be used to wake a sleeping fetus if no accelerations in 20-40 minutes.

9. False negative rate is extremely low (0.5-1%), making reactive NST highly reassuring for fetal well-being.

10. NST is safe, painless, and non-invasive with no risk to mother or baby, making it ideal for frequent monitoring.

Medical Disclaimer: This content is for educational purposes only and does not constitute medical advice. Always consult your healthcare provider for guidance specific to your pregnancy situation.